24.61
Forte Biosciences Inc (FBRX) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
-
|
- | - | 1.314 | - |
| Operating Expenses |
58.76%
18.38
|
11.58 | 16.12 | 7.351 | 8.629 |
| Operating Income/Loss |
58.76%
-18.38
|
-11.58 | -16.12 | -7.351 | -8.629 |
| Income/Loss From Continuing Operations Before Tax |
57.19%
-17.68
|
-11.25 | -15.66 | -7.155 | -8.392 |
| Income/Loss From Continuing Operations After Tax |
57.19%
-17.68
|
-11.25 | -15.66 | -7.155 | -8.392 |
|
|
57.19%
-17.68
|
-11.25 | -15.66 | -7.155 | -8.392 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Earnings Per Share |
3.13%
-0.99
|
-0.96 | -1.37 | 3.18 | -4.54 |
| Diluted Earnings Per Share |
3.13%
-0.99
|
-0.96 | -1.37 | 3.18 | -4.54 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):